From Bad To Worse: Valeant Investors Bail As Credibility Plunges

Investor allegiance to CEO Michael Pearson is fading; the company substantially reduced 2016 sales and earnings guidance just weeks after his return.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet